United States · FDA National Drug Code directory
NAPROXEN SODIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51013-137_9a223804-f229-442b-85a9-7f0f8fd74ba1
- Product NDC
- 51013-137
- Form
- CAPSULE, LIQUID FILLED
- Composition / generic term
- Naproxen Sodium
- Labeler
- PuraCap Pharmaceutical LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180320
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (51013-137-15) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE · 51013-137-15
- 1 BOTTLE in 1 CARTON (51013-137-28) / 160 CAPSULE, LIQUID FILLED in 1 BOTTLE · 51013-137-28
- 160 CAPSULE, LIQUID FILLED in 1 BOTTLE (51013-137-60) · 51013-137-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →